Taxotere Side Effects & Breast Cancer Survivors
Picture this. You’ve been diagnosed with breast cancer. It’s terrifying, but you and your family know that you can beat cancer. The reality sets in that you will likely have chemotherapy as part of your treatment; which has many difficult side effects including the loss of hair, even after the patient is in remission. There are dozens of chemotherapy drugs used to treat breast cancer. But there will come a time when the chemo ends and the mirror image looking back at you will be the healthy woman you remember before your diagnosis.
In fact, according to the American Cancer Society, most cancer patients usually experience thinning, loss of hair, or even baldness during chemotherapy, but luckily the hair usually returns shortly after completing treatment. Some patients even see hair growth in the final months of chemo. That statement changes if the patient used Taxotere (docetaxel) chemotherapy.
According to a study sponsored by Sanofi-Aventis known as TAX316 only 3.9% of women experience what the manufacturer calls “persistent hair loss”. So, does Docetaxel truly cause cancer patients to lose their hair permanently? Independent studies show the risks are much higher. For example, in contrast to the manufacturer-sponsored study, the NCRI Cancer Conference in 2013 featured a study that showed up to 15% of women who use this drug may never see hair regrowth. That applies to all hair – eyebrows, eyelashes, and hair on your head. An adverse effect that, according to oncologist Dr. Scot Sedlacek of Denver’s Rocky Mountain Cancer Centers, is “possibly the most dreaded adverse effect by the [cancer] patient” and can be “emotionally devastating”.
It’s difficult to explain the importance of hair, but the psychological impact is severe. Scientific studies on the psychological impact of alopecia show that hair is linked to one’s sense of self and identity, and lack of hair can result in experiences of depression and anxiety.
Survivors Learn About Taxotere’s Side Effects
Taxotere did not warn of the drug’s link to the risk of permanent alopecia. Thousands of women could have made a different decision about their treatments if they were given the facts.
The Fox Law Firm works with many clients who were prescribed this medication who are devastated, angry, and want answers. One question that many of our clients ask is: Did my doctor neglect to tell me about the potential consequence of lifelong physical disfigurement associated with this treatment?
While we can’t provide insight into what your doctor did and didn’t know, we can tell you that the manufacturer neglected to put any warning of permanent hair loss on the U.S. warning label until December of 2015. Yet, in the European warning label released in 2005, Sanofi references two studies suggesting the possibility of persistent alopecia as a side effect.
U.S. law requires manufacturers to warn consumers of potential side effects associated with their drugs. Sanofi-Aventis did not warn U.S. consumers of the possibility of lifelong baldness associated with the drug. Women across the country treated with Taxotere are speaking out. Many of them are heading to the court system to pursue justice for manufacturer’s blatant neglect to inform them of the risks associated with their treatment.
Join Other Breast Cancer Survivors & Fight Against Permanent Hair Loss
There are hundreds of thousands of women in the U.S. alone that are experiencing a decreased quality of life, negative body image, and symptoms of depression. This all of which may have been avoided if Sanofi-Aventis had disclosed the common adverse effect associated with their product, thus giving patients a choice of whether to take the risk of suffering permanent alopecia. Breast cancer survivors across the world are speaking out about this injustice.
Unfortunately there is a limited time to act. Each state in the U.S. has a different Statute of Limitations to pursue claims. In other words, each state has a different amount of time allowed to plaintiffs to pursue a case. This is why you need to call The Fox Law Firm at 1-866-FOX-FIRM now for your free case evaluation.
As of April 2017, almost 1,000 cases have been filed against the manufacturer. There are thousands of women that may not know that the persistent loss of their hair is linked to Taxotere, or have yet to file a claim.
We are passionate about educating survivors on the realities of chemotherapy treatment and helping them navigate their options during this difficult time. We believe Sanofi-Aventis should be held responsible for withholding information that could have enabled women to make a more informed choice about their healthcare options.